HK1004985A1 - N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists - Google Patents
N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonistsInfo
- Publication number
- HK1004985A1 HK1004985A1 HK98103726A HK98103726A HK1004985A1 HK 1004985 A1 HK1004985 A1 HK 1004985A1 HK 98103726 A HK98103726 A HK 98103726A HK 98103726 A HK98103726 A HK 98103726A HK 1004985 A1 HK1004985 A1 HK 1004985A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- beta
- piperidinylcarbonyl
- alanine derivatives
- paf antagonists
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939319561A GB9319561D0 (en) | 1993-09-22 | 1993-09-22 | Beta-alanine derivative and a process for preparation thereof |
| GB9413936A GB9413936D0 (en) | 1994-07-11 | 1994-07-11 | Beta-Alanine derivative and a process for the preparation thereof |
| PCT/JP1994/001550 WO1995008536A1 (en) | 1993-09-22 | 1994-09-21 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1004985A1 true HK1004985A1 (en) | 1998-12-18 |
Family
ID=26303555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98103726A HK1004985A1 (en) | 1993-09-22 | 1998-05-01 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6380215B1 (xx) |
| EP (2) | EP0669912B1 (xx) |
| CN (1) | CN1041919C (xx) |
| AT (1) | ATE210118T1 (xx) |
| AU (1) | AU684547B2 (xx) |
| CA (1) | CA2157792C (xx) |
| DE (1) | DE69429328T2 (xx) |
| DK (1) | DK0669912T3 (xx) |
| ES (1) | ES2164109T3 (xx) |
| HK (1) | HK1004985A1 (xx) |
| HU (1) | HUT73174A (xx) |
| IL (3) | IL111036A (xx) |
| PT (1) | PT669912E (xx) |
| RU (1) | RU2161155C2 (xx) |
| TW (1) | TW401414B (xx) |
| WO (1) | WO1995008536A1 (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010051730A1 (en) * | 1993-09-22 | 2001-12-13 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivative and a process for the preparation thereof |
| JPH11502224A (ja) * | 1995-03-17 | 1999-02-23 | 藤沢薬品工業株式会社 | Ｎ−アシルピペリジニルカルボニルアミノカルボン酸、およびグリコプロテインＩＩＢ／ＩＩＩａ拮抗剤およびフィブリノーゲン血小板凝集抑制剤としてのその用途 |
| EP0888302A1 (en) * | 1996-03-13 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| GEP20002187B (en) * | 1996-05-01 | 2000-07-25 | Ortho Pharma Corp | Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation |
| SI0923555T1 (en) * | 1996-05-01 | 2005-10-31 | Ortho-Mcneil Pharmaceutical, Inc. | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| EP1000030A1 (en) * | 1997-07-14 | 2000-05-17 | Phytera Symbion ApS | Piperidine oligomers and combinatorial libraries thereof |
| US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| WO1999025685A1 (en) * | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| AU769718B2 (en) * | 1998-10-12 | 2004-02-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing beta-alanine derivative |
| AUPP646598A0 (en) | 1998-10-12 | 1998-11-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing alpha-alanine derivative |
| BR0010652A (pt) * | 1999-03-22 | 2002-07-16 | Ortho Mcneil Pharm Inc | Processo de preparação de ácido [s-(r*,s*)]-beta-[[[1-[1-oxo-3-(4-piperidinil)propil]-3-piperi dinil]carbonil]amino]-3-piridinapropanóico e derivados |
| BR0007183A (pt) | 1999-09-29 | 2002-02-05 | Ortho Mcneil Pharm Inc | Isonipectoamidas para o tratamento de distúrbios mediados por integrina |
| AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
| JP2004529918A (ja) | 2001-04-09 | 2004-09-30 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物 |
| EP2404899A1 (en) | 2004-02-25 | 2012-01-11 | Astellas Pharma Inc. | Contrast medium for thrombus detection |
| ES2621379T3 (es) | 2011-08-17 | 2017-07-03 | Piramal Imaging Sa | Compuestos para la unión a la glicoproteína IIb/IIIa específica de las plaquetas y su utilización para la formación de imágenes de trombos |
| JP2016508507A (ja) | 2013-02-12 | 2016-03-22 | バイエル・ファルマ・アクティエンゲゼルシャフト | 血小板特異的糖タンパク質ＩＩｂ／ＩＩＩａに結合するための金属キレート化合物 |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03257624A (ja) * | 1990-03-08 | 1991-11-18 | Fujitsu Ltd | 画面言語方式 |
| CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
| CA2054627A1 (en) * | 1991-02-13 | 1992-08-14 | Yea-Shun Cheng | Polypeptide skeletal muscle relaxants |
| HUT68769A (en) * | 1991-05-07 | 1995-07-28 | Merck & Co Inc | FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
-
1994
- 1994-09-21 ES ES94927076T patent/ES2164109T3/es not_active Expired - Lifetime
- 1994-09-21 TW TW083108696A patent/TW401414B/zh not_active IP Right Cessation
- 1994-09-21 AU AU76657/94A patent/AU684547B2/en not_active Ceased
- 1994-09-21 DK DK94927076T patent/DK0669912T3/da active
- 1994-09-21 CA CA002157792A patent/CA2157792C/en not_active Expired - Lifetime
- 1994-09-21 PT PT94927076T patent/PT669912E/pt unknown
- 1994-09-21 WO PCT/JP1994/001550 patent/WO1995008536A1/en active IP Right Grant
- 1994-09-21 EP EP94927076A patent/EP0669912B1/en not_active Expired - Lifetime
- 1994-09-21 US US08/495,572 patent/US6380215B1/en not_active Expired - Lifetime
- 1994-09-21 EP EP01102827A patent/EP1106606A3/en not_active Withdrawn
- 1994-09-21 RU RU95112456/04A patent/RU2161155C2/ru not_active IP Right Cessation
- 1994-09-21 HU HU9501845A patent/HUT73174A/hu unknown
- 1994-09-21 CN CN94190981A patent/CN1041919C/zh not_active Expired - Fee Related
- 1994-09-21 DE DE69429328T patent/DE69429328T2/de not_active Expired - Lifetime
- 1994-09-21 AT AT94927076T patent/ATE210118T1/de not_active IP Right Cessation
- 1994-09-22 IL IL11103694A patent/IL111036A/xx not_active IP Right Cessation
- 1994-09-22 IL IL12682594A patent/IL126825A/xx not_active IP Right Cessation
-
1998
- 1998-05-01 HK HK98103726A patent/HK1004985A1/xx not_active IP Right Cessation
- 1998-10-30 IL IL12682598A patent/IL126825A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69429328D1 (de) | 2002-01-17 |
| ATE210118T1 (de) | 2001-12-15 |
| IL126825A0 (en) | 1999-08-17 |
| HUT73174A (en) | 1996-06-28 |
| CA2157792A1 (en) | 1995-03-30 |
| AU7665794A (en) | 1995-04-10 |
| HU9501845D0 (en) | 1995-08-28 |
| US6380215B1 (en) | 2002-04-30 |
| DE69429328T2 (de) | 2002-06-13 |
| EP0669912A1 (en) | 1995-09-06 |
| AU684547B2 (en) | 1997-12-18 |
| RU95112456A (ru) | 1997-04-20 |
| CN1041919C (zh) | 1999-02-03 |
| DK0669912T3 (da) | 2002-03-04 |
| WO1995008536A1 (en) | 1995-03-30 |
| PT669912E (pt) | 2002-03-28 |
| EP0669912B1 (en) | 2001-12-05 |
| ES2164109T3 (es) | 2002-02-16 |
| IL111036A0 (en) | 1994-11-28 |
| CA2157792C (en) | 2005-05-24 |
| EP1106606A3 (en) | 2003-10-22 |
| IL111036A (en) | 1999-07-14 |
| CN1116847A (zh) | 1996-02-14 |
| RU2161155C2 (ru) | 2000-12-27 |
| EP1106606A2 (en) | 2001-06-13 |
| IL126825A (en) | 1999-09-22 |
| TW401414B (en) | 2000-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1004985A1 (en) | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | |
| EA200400432A1 (ru) | Производные мочевины | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| HU9303145D0 (en) | Process for producing of fibrinogen receptor antagonist compounds and pharmaceutical compositions containing them as medical agent | |
| ES2150489T3 (es) | 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas. | |
| MX9604378A (es) | Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios. | |
| HK1044527A1 (zh) | 對位取代的苯乙烯衍生物和其作為整合素劑的用途 | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
| WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| SE9901573D0 (sv) | New compounds | |
| PL1682528T3 (pl) | Pochodne benzo[b][1,4]dioksepiny | |
| DE69431035T2 (de) | 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| MD1560G2 (ro) | Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri | |
| FI935800A (fi) | Masennuksenvastaisia ja Parkinsonin taudin vastaisia yhdisteitä | |
| DE69315699T2 (de) | Inhibitoren gegen die aggregation von blutplättchen | |
| DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| EA200300900A1 (ru) | Замещенные амины (варианты), способ их получения и их применение в качестве ингибиторов транспорта глицина (варианты), композиция (варианты), промежуточный иодид и способ его получения, способ лечения пациента (варианты) | |
| MY133957A (en) | "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor" | |
| EE03488B1 (et) | Meetod anhüdroekgoniini estrite valmistamiseks | |
| MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. | |
| MY135855A (en) | "pyrrolopyrimidinone derivatives, process of preparation and use" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20070921 |